Adverse events for biologics in patients with CRSwNP: A meta-analysis

被引：10
|
作者：
Shen, Yang [1 ]
Ke, Xia [1 ]
Hong, Suling [1 ]
Yang, Yucheng [1 ]
机构：
[1] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China
来源：
CLINICAL AND TRANSLATIONAL ALLERGY | 2022年 / 12卷 / 06期
基金：
中国国家自然科学基金;
关键词：
adverse event; biologics; chronic rhinosinusitis with nasal polyposis; meta-analysis; NASAL POLYPOSIS; MEPOLIZUMAB; EFFICACY; SAFETY;
D O I：
10.1002/clt2.12169
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
下载
收藏
页数：3
相关论文
共 50 条
  • [21] A bibliometric analysis of immune-related adverse events in cancer patients and a meta-analysis of immune-related adverse events in patients with hepatocellular carcinoma
    Wang, Bengang
    Hao, Xiangjun
    Yan, Jinshan
    Li, Xin
    Zhao, Mingfang
    Han, Tao
    JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2024, 12 (03) : 225 - 243
  • [22] Incidence of conjunctivitis adverse event in patients treated with biologics for atopic dermatitis: A systematic review and meta-analysis
    Alraddadi, Rose
    Alsamadani, Abdulrahman H.
    Kalantan, Mulham A.
    Aljefri, Yara E.
    Maaddawi, Hadeel A.
    Kadasa, Athoub N.
    Alturkistani, Rahaf F.
    Jfri, Abdulhadi H.
    JAAD INTERNATIONAL, 2023, 13 : 46 - 47
  • [23] BEVACIZUMAB RELATED ADVERSE EVENTS IN PATIENTS AFFECTED BY METASTATIC COLORECTAL CANCER: A META-ANALYSIS
    Cinquini, Michela
    Galfrascoli, Elena
    Rossi, Antonio
    Manazza, Andrea
    Damia, Giovanna
    Banna, Giuseppe
    Tosoni, Alicia
    Tiseo, Marcello
    Farina, Gabriella
    Garassino, Marina Chiara
    ANNALS OF ONCOLOGY, 2009, 20
  • [24] Discontinuation of Everolimus Due to Related and Unrelated Adverse Events in Cancer Patients: A Meta-Analysis
    Rogers, Sherise C.
    Garcia, Christine A.
    Wu, Shenhong
    CANCER INVESTIGATION, 2017, 35 (08) : 552 - 561
  • [25] An Updated Meta-Analysis of Fatal Adverse Events Caused by Bevacizumab Therapy in Cancer Patients
    Huang, Hongxin
    Zheng, Yayuan
    Zhu, Jianhong
    Zhang, Jingjing
    Chen, Huapu
    Chen, Xinggui
    PLOS ONE, 2014, 9 (03):
  • [26] Bevacizumab related adverse events in patients affected by metastatic colorectal cancer: a meta-analysis
    Galfrascoli, Elena
    Garassino, Marina C.
    Cinquini, Michela
    Rossi, Antonio
    Manazza, Andrea
    Damia, Giovanna
    Farina, Gabriella
    Muserra, Gaetana
    PHARMACY WORLD & SCIENCE, 2010, 32 (02): : 239 - 239
  • [27] Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis
    Xu, Wentao
    Bai, Zhaohui
    Shang, Yiyang
    Wang, Jing
    Wong, Yujun
    Qi, Xingshun
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [28] Bevacizumab related adverse events in patients affected by metastatic colorectal cancer: a meta-analysis
    Galfrascoli, E.
    Cinquini, M.
    Rossi, A.
    Manazza, A.
    Damia, G.
    Banna, G.
    Tosoni, A.
    Tiseo, M.
    Farina, G.
    Garassino, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 343 - 343
  • [29] Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis
    Mattay, Shivani Shah
    Zamani, Mohammad
    Saturno, Dany
    Loftus Jr, Edward V.
    Ciorba, Matthew A.
    Yarur, Andres
    Singh, Siddharth
    Deepak, Parakkal
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (05) : 961 - 970.e12
  • [30] ADVERSE EVENTS WITH USE OF USTEKINUMAB: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Rolston, Vineet S.
    Kimmel, Jessica
    Hudesman, David
    Chang, Shannon
    Bosworth, Brian P.
    Popov, Violeta
    GASTROENTEROLOGY, 2017, 152 (05) : S578 - S579
12345